Last reviewed · How we verify

[14C]-darigabat

Cerevel Therapeutics, LLC · Phase 1 active Small molecule

At a glance

Generic name[14C]-darigabat
Also known asCVL-865; PF-06372865
SponsorCerevel Therapeutics, LLC
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.